Cited by 1,862Influenza Virus Research StudiesCarbohydrate Chemistry and SynthesisComputational Drug Discovery Methods

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Rational design of potent sialidase-based inhibitors of influenza virus replication

von Itzstein, Mark, Wu, Wen-Yang, Kok, Gaik B., Pegg, Michael S., Dyason, Jeffrey C., Jin, Betty, Van Phan, Tho, Smythe, Mark L., White, Hume F., Oliver, Stuart W., Colman, Peter M., Varghese, Joseph N., Ryan, D. Michael, Woods, Jacqueline M., Bethell, Richard C., Hotham, Vanessa J., Cameron, Janet M., Penn, Charles R.·1993·Nature

DOI 10.1038/363418a0

Open this paper in CoChat — free account

Abstract

Two potent inhibitors based on the crystal structure of influenza virus sialidase have been designed. These compounds are effective inhibitors not only of the enzyme, but also of the virus in cell culture and in animal models. The results provide an example of the power of rational, computer-assisted drug design, as well as indicating significant progress in the development of a new therapeutic or prophylactic treatment for influenza infection.

Integrity signals

Registry

Crossref · 10.1038/363418a0

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,642
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,537
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation
Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623
Influenza virus M2 protein has ion channel activity
Pinto, L. H., Holsinger, L. J., & Lamb, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90452-i · Cited by 1,230
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution
Varghese, J. N., Laver, W. G., & Colman, P. M. (1983) · Nature · doi:10.1038/303035a0 · Cited by 891
Self-citation
The molecular basis of the specific anti‐influenza action of amantadine.
Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04038.x · Cited by 855
Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate
Potier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90362-2 · Cited by 816
Structure of the catalytic and antigenic sites in influenza virus neuraminidase
Colman, P. M., Varghese, J. N., & Laver, W. G. (1983) · Nature · doi:10.1038/303041a0 · Cited by 806
Self-citation
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 788
A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors
Henderson, P. J. F. (1972) · Biochemical Journal · doi:10.1042/bj1270321 · Cited by 524

Flagged first, then by citations

Show all 38 references

Research works printed but not linked: 6

Chong, A. K. J., Pegg, M. S. & von Itzstein, M. Biochem. Int. 24, 165–171 (1991).
Gottschalk, A. Biochim. biophys. Acta 23, 645–646 (1957). · DOI
Colman, P. M. & Ward, C. W. Curr. Top. microbiol. Immun. 114, 117–255 (1985).
Palese, P. & Schulman, J. L. in Chemoprophylaxis and Virus Infections of the Upper Respiratory Tract Vol. 1 (ed. Oxford, J. S.) 189–205 (CRC, Cleveland, 1977).
von Itzstein, M., Jin, B., Wu, W.-Y. & Chandler, M. Carbohydr. Res. (in the press).
von Itzstein, M., Wu, W.-Y., Phan, T. V., Danylec, B. & Jin, B. Chem. Abs. 117, 49151y (1991).

Sorted by citations

Items 201–300 of 1,001

Function and 3D Structure of the N-Glycans on Glycoproteins
Nagae, M., & Yamaguchi, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078398 · Cited by 134
A comprehensive map of the influenza A virus replication cycle
Matsuoka, Y., Matsumae, H., Katoh, M., Eisfeld, A. J., Neumann, G., Hase, T., Ghosh, S., Shoemaker, J. E., Lopes, T. J. S., Watanabe, T., et al. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-97 · Cited by 138
Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications
van der Sluijs, K. F., van der Poll, T., Lutter, R., Juffermans, N. P., & Schultz, M. J. (2010) · Critical Care · doi:10.1186/cc8893 · Cited by 136
Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells
Govorkova, E. A., Fang, H., Tan, M., & Webster, R. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4855-4863.2004 · Cited by 132
Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance
Burnham, A. J., Baranovich, T., & Govorkova, E. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.023 · Cited by 131
Zanamivir
Dunn, C. J., & Goa, K. L. (1999) · Drugs · doi:10.2165/00003495-199958040-00016 · Cited by 133
Pandemic Influenza as a Current Threat
Yen, H., & Webster, R. G. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-92165-3_1 · Cited by 134
Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases
Varghese, J. N., Colman, P. M., van Donkelaar, A., Blick, T., Sahasrabudhe, A., & McKimm‐Breschkin, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11808 · Cited by 130
Self-citation
Medical Management of Influenza Infection
Moscona, A. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061506.213121 · Cited by 129
The Effect of Electrostatic Interactions on Conformational Equilibria of Multiply Substituted Tetrahydropyran Oxocarbenium Ions
Yang, M. T., & Woerpel, K. A. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo8017846 · Cited by 129
Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors
Hastings, J. C., Selnick, H. G., Wolanski, B., & Tomassini, J. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1304 · Cited by 129
Antituberculosis Drug Research: A Critical Overview
Beena, & Rawat, D. S. (2012) · Medicinal Research Reviews · doi:10.1002/med.21262 · Cited by 129
Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
Wu, C., Yin, W., Jiang, Y., & Xu, H. E. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00851-w · Cited by 138
An efficient process for production of n-acetylneuraminic acid using n-acetylneuraminic acid aldolase
Mahmoudian, M., NOBLE, D., Drake, C. S., Middleton, R. F., Montgomery, D. S., Piercey, J. E., Ramlakhan, D., Todd, M., & Dawson, M. J. (1997) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(96)00180-9 · Cited by 127
Genomic and genetic research on bursate nematodes: significance, implications and prospects
Gasser, R. B., & Newton, S. E. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00021-7 · Cited by 130
In silico approaches and tools for the prediction of drug metabolism and fate: A review
Kazmi, S. R., Ren, J., Yu, M., Jung, C., & Na, D. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.01.008 · Cited by 128
How to overcome resistance of influenza A viruses against adamantane derivatives
Scholtissek, C., Quack, G., Klenk, H., & Webster, R. G. (1998) · Antiviral Research · doi:10.1016/s0166-3542(97)00061-2 · Cited by 125
Identification of Five Structurally Unrelated Quorum-Sensing Inhibitors of Pseudomonas aeruginosa from a Natural-Derivative Database
Tan, S. Y.-Y., Chua, S. L., Chen, Y., Rice, S. A., Kjelleberg, S. J., Nielsen, T. E., Yang, L., & Givskov, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00955-13 · Cited by 124
Synthetic Strategies for Oseltamivir Phosphate
Shibasaki, M., & Kanai, M. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200800033 · Cited by 123
Chance Favors the Prepared Mind - From Serendipity to Rational Drug Design
Kubinyi, H. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036635 · Cited by 123
Anti-influenza agents from Traditional Chinese Medicine
Hu, G., Wang, Y., Xu, J., Gu, Q., Liu, H.-B., Xiao, P., Zhou, J., Liu, Y., Yang, Z., & Su, H. (2010) · Natural Product Reports · doi:10.1039/c0np00005a · Cited by 123
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
Pizzorno, A., Padey, B., Terrier, O., & Rosa-Calatrava, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00531 · Cited by 122
In vitro and in vivo assay systems for study of influenza virus inhibitors
Sidwell, R. W., & Smee, D. F. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00125-x · Cited by 124
Structural basis for oseltamivir resistance of influenza viruses
Collins, P. J., Haire, L. F., Lin, Y., Liu, J., Russell, R. J., Walker, P. A., Martin, S. R., Daniels, R. S., Gregory, V., Skehel, J. J., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.017 · Cited by 121
Strategies for the Development of Glycomimetic Drug Candidates
Hevey, R. (2019) · Pharmaceuticals · doi:10.3390/ph12020055 · Cited by 130
Antiviral Management of Seasonal and Pandemic Influenza
Hayden, F. G., & Pavia, A. T. (2006) · The Journal of Infectious Diseases · doi:10.1086/507552 · Cited by 123
New Approaches to Influenza Chemotherapy
Calfee, D. P., & Hayden, F. G. (1998) · Drugs · doi:10.2165/00003495-199856040-00003 · Cited by 120
Emerging Antiviral Strategies to Interfere with Influenza Virus Entry
Vanderlinden, E., & Naesens, L. M. J. (2013) · Medicinal Research Reviews · doi:10.1002/med.21289 · Cited by 119
Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus
Li, Q., Sun, X., Li, Z., Liu, Y., Vavricka, C. J., Qi, J., & Gao, G. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211037109 · Cited by 119
The role of antivirals in the control of influenza
Monto, A. S. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00075-6 · Cited by 121
A Synthesis of Tamiflu by Using a Barium‐Catalyzed Asymmetric Diels–Alder‐Type Reaction
Yamatsugu, K., Yin, L., Kamijo, S., Kimura, Y., Kanai, M., & Shibasaki, M. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200804777 · Cited by 119
Design of Inhibitors of Glycogen Phosphorylase: A Study of .alpha.- and .beta.-C-Glucosides and 1-Thio-.beta.-D-glucose Compounds
Watson, K. A., Mitchell, E. P., Johnson, L. N., Bichard, C. J. F., Orchard, M. G., Fleet, G. W. J., Oikonomakos, N. G., Leonidas, D. D., & Son, J. C. (1994) · Biochemistry · doi:10.1021/bi00185a011 · Cited by 119
Minimization of a Polypeptide Hormone
Li, B., Tom, J. Y. K., Oare, D. A., Yen, R., Fairbrother, W. J., Wells, J. A., & Cunningham, B. C. (1995) · Science · doi:10.1126/science.270.5242.1657 · Cited by 121
Identification of a Broad-Spectrum Antiviral Small Molecule against Severe Acute Respiratory Syndrome Coronavirus and Ebola, Hendra, and Nipah Viruses by Using a Novel High-Throughput Screening Assay
Elshabrawy, H. A., Fan, J.-L., Haddad, C., Ratia, K. M., Broder, C. C., Caffrey, M. S., & Prabhakar, B. S. (2014) · Journal of Virology · doi:10.1128/jvi.03050-13 · Cited by 117
Design and synthesis of glycomimetics: Recent advances
Tamburrini, A., Colombo, C., & Bernardi, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21625 · Cited by 116
The three-dimensional structure of N -acetylneuraminate lyase from Escherichia coli
Izard, T., Lawrence, M. C., Malby, R. L., Lilley, G. G., & Colman, P. M. (1994) · Structure · doi:10.1016/s0969-2126(00)00038-1 · Cited by 116
Self-citation
Structure-based design of parasitic protease inhibitors
Li, R., Chen, X., Gong, B., Selzer, P. M., Li, Z., Davidson, E. A., Kurzban, G. P., Miller, R. E., Nuzum, E. O., McKerrow, J. H., et al. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(96)00136-8 · Cited by 116
Role of neuraminidase in influenza virus-induced apoptosis.
Morris, S. J., Price, G. E., Barnett, J. M., Hiscox, S. A., Smith, H. C., & Sweet, C. R. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-1-137 · Cited by 116
Genetic algorithms in molecular recognition and design
Willett, P. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)89015-0 · Cited by 115
A Study of the Active Site of Influenza Virus Sialidase: An Approach to the Rational Design of Novel Anti-influenza Drugs
von Itzstein, M., Dyason, J. C., Oliver, S. W., White, H. F., Wu, W.-Y., Kok, G. B., & Pegg, M. S. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950294c · Cited by 115
Self-citation
The genesis of high-throughput structure-based drug discovery using protein crystallography
Kühn, P., Wilson, K. P., Patch, M. G., & Stevens, R. C. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00361-7 · Cited by 115
Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
Matsubara, T., Onishi, A., Saito, T., Shimada, A., Inoue, H., Taki, T., Nagata, K., Okahata, Y., & Sato, T. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1002183 · Cited by 114
Parallelization of Molecular Docking: A Review
Dong, D., Xu, Z., Zhong, W., & Peng, S. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180821145215 · Cited by 118
Chemoenzymatic Preparation of Novel Cyclic Imine Sugars and Rapid Biological Activity Evaluation Using Electrospray Mass Spectrometry and Kinetic Analysis
Takayama, S., Martin, R., Wu, J., Laslo, K., Siuzdak, G. E., & Wong, C. (1997) · Journal of the American Chemical Society · doi:10.1021/ja971695f · Cited by 114
What has computer-aided molecular design ever done for drug discovery?
Clark, D. E. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.2.103 · Cited by 113
Ligand Mapping on Protein Surfaces by the 3D-RISM Theory: Toward Computational Fragment-Based Drug Design
Imai, T., Oda, K., Kovalenko, A., Hirata, F., & Kidera, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905029t · Cited by 112
Antivirals Targeting Influenza A Virus
Das, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300455c · Cited by 112
Sialidase expression in activated human T lymphocytes influences production of IFN-γ
Nan, X., Carubelli, I., & Stamatos, N. M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105692 · Cited by 111
Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A Viruses
Ziegler, T. T., Hemphill, M. L., Ziegler, M., Perez‐Oronoz, G., Klimov, A. I., Hampson, A. W., Regnery, H. L., & Cox, N. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314994 · Cited by 113
Nitro compounds as the core structures of promising energetic materials and versatile reagents for organic synthesis
Zlotin, S. G., Dalinger, I. L., Makhova, N. N., & Tartakovsky, V. A. (2019) · Russian Chemical Reviews · doi:10.1070/rcr4908 · Cited by 111
Simple and large-scale production of N-acetylneuraminic acid from N-acetyl-d-glucosamine and pyruvate using N-acyl-d-glucosamine 2-epimerase and N-acetylneuraminate lyase
Maru, I., Ohnishi, J., Ohta, Y., & Tsukada, Y. (1998) · Carbohydrate Research · doi:10.1016/s0008-6215(97)10106-9 · Cited by 111
Potential Risks Associated with the Proposed Widespread Use of Tamiflu
Singer, A. C., Nunn, M. A., Gould, E. A., & Johnson, A. C. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9574 · Cited by 110
Discovery and Protein Engineering of Biocatalysts for Organic Synthesis
Behrens, G. A., Hummel, A., Padhi, S. K., Schätzle, S., & Bornscheuer, U. T. (2011) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201100446 · Cited by 109
The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2en
Blick, T., Sahasrabudhe, A., McDonald, M., Owens, I. J., Morley, P. J., Fenton, R. J., & McKimm‐Breschkin, J. L. (1998) · Virology · doi:10.1006/viro.1998.9194 · Cited by 108
Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities
Li, J., Zheng, M., Tang, W., He, P., Zhu, W., Li, T., Zuo, J., Liu, H. S., & Jiang, H. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.047 · Cited by 108
Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir
Rameix‐Welti, M., Agou, F., Buchy, P., Mardy, S., Aubin, J., Véron, M., van der Werf, S., & Naffakh, N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00645-06 · Cited by 108
Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe
Alimi, Y. H., Lim, W. S., Lansbury, L., Leonardi‐Bee, J., & Nguyen‐Van‐Tam, J. S. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.07.019 · Cited by 108
Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection
Lee, S. M.-Y., & Yen, H. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.09.013 · Cited by 108
Influenza virus genetics
Brown, E. G. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)89026-5 · Cited by 107
Human mannan‐binding lectin inhibits the infection of influenza A virus without complement
Kase, Suzuki, ※., Kawai, Sakamoto, Ohtani, Eda, Maeda, Okuno, Kurimura, & WAKAMIYA, W. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00781.x · Cited by 107
SYNTHESIS AND REACTIONS OF UNSATURATED SUGARS
Ferrier, R. J., & Hoberg, J. O. (2003) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(03)58003-9 · Cited by 107
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus–Host Interaction
Kim, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124549 · Cited by 124
Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist
Schnaar, R. L. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.057 · Cited by 105
Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies
Barnett, J. M., Cadman, A., Gor, D., Dempsey, M. H., Walters, M. S., Candlin, A., Tisdale, M., Morley, P. J., Owens, I. J., Fenton, R. J., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.78-87.2000 · Cited by 104
Using bacterial genomes and essential genes for the development of new antibiotics
Fields, F. R., Lee, S. W., & McConnell, M. J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.12.002 · Cited by 103
Computer-Aided Drug Design: Lead Discovery and Optimization
Xiang, M., Cao, Y., Fan, W., Chen, L., & Mo, Y. (2012) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620712799361825 · Cited by 102
Structure-based discovery and in-parallel optimization of novelcompetitive inhibitors of thymidylate synthase
Tondi, D., Slomczynska, U., Costi, M. P., Watterson, D. M., Ghelli, S., & Shoichet, B. K. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80077-5 · Cited by 102
Application of computational methods for anticancer drug discovery, design, and optimization
Prada‐Gracia, D., Huerta‐Yépez, S., & Moreno‐Vargas, L. M. (2016) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2016.10.006 · Cited by 105
FLAP: GRID Molecular Interaction Fields in Virtual Screening. Validation using the DUD Data Set
Cross, S., Baroni, M., Carosati, E., Benedetti, P., & Clementi, S. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100221g · Cited by 104
A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals
Noah, J. W., Severson, W. E., Noah, D. L., Rasmussen, L. A., White, E. L., & Jonsson, C. B. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.07.006 · Cited by 101
Trypanosomatid Parasites Causing Neglected Diseases
Nussbaum, K., Honek, J. F., Cadmus, C. C. V. C., & Efferth, T. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790979953 · Cited by 101
Zanamivir
Freund, B., Gravenstein, S., Elliott, M. J., & Miller, I. A. (1999) · Drug Safety · doi:10.2165/00002018-199921040-00003 · Cited by 105
Di-, Tri-, and Tetravalent Dendritic Galabiosides That Inhibit Hemagglutination by Streptococcus suis at Nanomolar Concentration
Hansen, H. C., Haataja, S., Finne, J., & Magnusson, G. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970859p · Cited by 101
In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication
Kati, W. M., Montgomery, D., Carrick, R. J., Gubareva, L. V., Maring, C. J., McDaniel, K. F., Steffy, K. R., Molla, A., Hayden, F. G., Kempf, D. J., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1014-1021.2002 · Cited by 103
Genomic Signature and Mutation Trend Analysis of Pandemic (H1N1) 2009 Influenza A Virus
Pan, C., Cheung, B., Tan, S., Li, C., Li, L., Liu, S., & Jiang, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009549 · Cited by 100
The impact of in silico screening in the discovery of novel and safer drug candidates
Rognan, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.034 · Cited by 105
Burden of influenza B virus infection and considerations for clinical management
Zaraket, H., Hurt, A. C., Clinch, B., Barr, I., & Lee, N. L. S. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104970 · Cited by 100
Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors
Ji, H., Stanton, B. Z., Igarashi, J., Li, H., Pavel Martasek, E., Roman, L. J., Poulos, T. L., & Silverman, R. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0772041 · Cited by 100
Sialidase Activity of Influenza A Virus in an Endocytic Pathway Enhances Viral Replication
Suzuki, T., Takahashi, T., Guo, C.-T., Hidari, K. I. P. J., Miyamoto, D., Goto, H., Kawaoka, Y., & Suzuki, Y. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11705-11715.2005 · Cited by 99
Realizing the promise of chemical glycobiology
Wang, L., & Davis, B. G. (2013) · Chemical Science · doi:10.1039/c3sc50877c · Cited by 97
Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities
Sriwilaijaroen, N., Wilairat, P., Hiramatsu, H., Takahashi, T., Suzuki, T., Ito, M., Ito, Y., Tashiro, M., & Suzuki, Y. (2009) · Virology Journal · doi:10.1186/1743-422x-6-124 · Cited by 99
A comprehensive review of edible bird's nest
Dai, Y.-W., Cao, J., Wang, Y., Chen, Y., & Jiang, L. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109875 · Cited by 98
Aurintricarboxylic acid inhibits influenza virus neuraminidase
Hung, H., Tseng, C., Yang, J., Ju, Y.-W., Tseng, S.-N., Chen, Y., Chao, Y.-S., Hsieh, H., Shih, S., & Hsu, J. T.-A. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.006 · Cited by 98
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
Hurt, A. C., Ho, H.-T., & Barr, I. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.795 · Cited by 96
Mimics of Complex Carbohydrates Recognized by Receptors
Wong, C. (1999) · Accounts of Chemical Research · doi:10.1021/ar960237t · Cited by 98
Structures of Aromatic Inhibitors of Influenza Virus Neuraminidase
Jedrzejas, M. J., Singh, S., Brouillette, W. J., Laver, W. G., Air, G. M., & Luo, M. (1995) · Biochemistry · doi:10.1021/bi00010a003 · Cited by 98
Development of effective anti-influenza drugs: congeners and conjugates – a review
Shie, J., & Fang, J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0567-0 · Cited by 97
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae
Sender, V., Hentrich, K., & Henriques‐Normark, B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.643326 · Cited by 98
Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
Zürcher, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl321 · Cited by 97
Methods and Applications of Structure Based Pharmacophores in Drug Discovery
Pirhadi, S., Shiri, F., & Ghasemi, J. B. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313090006 · Cited by 96
Analysis of inhibitor binding in influenza virus neuraminidase
Smith, B. J., Colman, P. M., von Itzstein, M., Danylec, B., & Varghese, J. N. (2001) · Protein Science · doi:10.1110/ps.41801 · Cited by 96
Self-citation
Carbohydrate based Potential Chemotherapeutic Agents: Recent Developments and their Scope in Future Drug Discovery
Tiwari, V. K., Mishra, R. C., Sharma, A., & Tripathi, R. P. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712803832654 · Cited by 97
Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers
Wattanagoon, Y., Stepniewska, K., Lindegårdh, N., Pukrittayakamee, S., Silachamroon, U., Piyaphanee, W., Singtoroj, T., Hanpithakpong, W., Davies, G., Tärning, J., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00588-08 · Cited by 97
Influenza: diagnosis, management, and prophylaxis
Wiselka, M. J. (1994) · BMJ · doi:10.1136/bmj.308.6940.1341 · Cited by 96
A Practical Synthesis of Zanamivir Phosphonate Congeners with Potent Anti-influenza Activity
Shie, J., Fang, J., Lai, P., Wen, W., Wang, S., Cheng, Y. E., Tsai, K., Yang, A., & Wong, C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207892q · Cited by 95
Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors
Vavricka, C. J., Liu, Y., Kiyota, H., Sriwilaijaroen, N., Qi, J., Tanaka, K., Wu, Y., Li, Q., Li, Y., Yan, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2487 · Cited by 95
Structure-based identification of a ricin inhibitor
Yan, X., Hollis, T., Svinth, M., Day, P., Monzingo, A. F., Milne, G. W. A., & Robertus, J. D. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0865 · Cited by 95
Neuraminidase inhibitor resistance in influenza viruses
Reece, P. A. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20951 · Cited by 93
Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets
Ilyushina, N. A., Seiler, J. P., Rehg, J. E., Webster, R. G., & Govorkova, E. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000933 · Cited by 94
Protein–carbohydrate interactions: learning lessons from nature
Williams, S. J. (2001) · Trends in biotechnology · doi:10.1016/s0167-7799(01)01699-7 · Cited by 94

Authors: von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., Colman, P. M., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hotham, V. J., Cameron, J. M., & Penn, C. R.
Affiliations: Monash University (AU)
Commonwealth Scientific and Industrial Research Organisation (AU)
ORCID: Smythe, Mark L.
Colman, Peter M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1993-06
Volume: 363
Issue: 6428
Pages: 418-423
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/363418a0
OpenAlex: W2086358466
Cited by: 1,862
References: 38
Citations by year: 2026: 27 · 2025: 25 · 2024: 34 · 2023: 30 · 2022: 46 · 2021: 50 · 2020: 60 · 2019: 50 · 2018: 58 · 2017: 45 · 2016: 68 · 2015: 48 · 2014: 71 · 2013: 83 · 2012: 84
FWCI: 58.57
Type: journal article
Language: en
Update notices: correction (1993-10-28)
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Griffith Research Online (submittedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords: influenza virus, sialidase inhibitors, neuraminidase, rational drug design, computer-aided drug design, antiviral agents, influenza treatment, prophylaxis, enzyme inhibition
MeSH terms: Animals, Antiviral Agents, Cell Line, Disease Models, Animal, Female, Ferrets, Guanidines, Humans, Influenza, Human, Models, Molecular, Neuraminidase, Influenza A virus, Viral Plaque Assay, Pyrans, Sheep, Sialic Acids, Virus Replication, Drug Design, Computer-Aided Design, Mice, Zanamivir

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rational design of potent sialidase-based inhibitors of influenza virus replication

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks